HUP0105351A2 - Pezsgő hashajtó készítmények és alkalmazásuk - Google Patents

Pezsgő hashajtó készítmények és alkalmazásuk

Info

Publication number
HUP0105351A2
HUP0105351A2 HU0105351A HUP0105351A HUP0105351A2 HU P0105351 A2 HUP0105351 A2 HU P0105351A2 HU 0105351 A HU0105351 A HU 0105351A HU P0105351 A HUP0105351 A HU P0105351A HU P0105351 A2 HUP0105351 A2 HU P0105351A2
Authority
HU
Hungary
Prior art keywords
effervescent
laxatives
peg
enables
polyethylene glycol
Prior art date
Application number
HU0105351A
Other languages
English (en)
Inventor
Bruce P. Daggy
Kenneth G. Mandel
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of HUP0105351A2 publication Critical patent/HUP0105351A2/hu
Publication of HUP0105351A3 publication Critical patent/HUP0105351A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány egy új hashajtóra vonatkozik, amely a jelenlegi stimulálóhatású hashajtókkal szemben előnyösebb kezelést tesz lehetővé. Agyógyszerkészítmény ozmotikus mennyiségű PEG 3350 vagy PEG 4000polietilén-glikolt valamint gyógyászatilag elfogadható, pezsgőanyagpárt tartalmaz. Ó
HU0105351A 1999-02-22 2000-02-22 Effervescent laxatives and their use HUP0105351A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12108999P 1999-02-22 1999-02-22

Publications (2)

Publication Number Publication Date
HUP0105351A2 true HUP0105351A2 (hu) 2002-05-29
HUP0105351A3 HUP0105351A3 (en) 2004-06-28

Family

ID=22394460

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0105351A HUP0105351A3 (en) 1999-02-22 2000-02-22 Effervescent laxatives and their use

Country Status (14)

Country Link
EP (1) EP1154765A4 (hu)
JP (1) JP2002537248A (hu)
KR (1) KR20010102323A (hu)
CN (1) CN1341016A (hu)
AU (1) AU3604600A (hu)
BR (1) BR0008385A (hu)
CA (1) CA2362355A1 (hu)
CZ (1) CZ20013043A3 (hu)
EA (1) EA003064B1 (hu)
HK (1) HK1043046A1 (hu)
HU (1) HUP0105351A3 (hu)
PL (1) PL349360A1 (hu)
WO (1) WO2000048585A1 (hu)
ZA (1) ZA200106888B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048901A (en) * 1999-04-20 2000-04-11 Braintree Laboratories, Inc. Method of reducing intestinal gas, cramping and anorectal irritation
DE102004023288A1 (de) * 2004-05-11 2005-12-15 Stefan Spiess Macrogol-Präparat
AU2005320935B2 (en) * 2004-12-30 2012-02-16 Given Imaging Ltd. Device, system and method for in-vivo examination
CN101002832B (zh) * 2006-09-02 2011-01-05 江西农业大学 一种润肠通便速溶颗粒剂
LT2421373T (lt) 2009-04-21 2020-01-10 Dale R. Bachwich Gaubtinės žarnos lavažo sistema
CA2825808C (en) 2011-01-28 2020-09-01 William A. Shaver Method, composition and package for bowel cleansing
EP2773362A4 (en) * 2011-11-06 2015-08-26 Ssv Therapeutics Llc FORMULATIONS OF CONCENTRATED PRUNE PLUMS AND PREBIOTICS AS LAXATIVES AND FOOD SUPPLEMENTS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB942743A (en) * 1959-05-22 1963-11-27 Welloome Foundation Ltd Oestrogen preparations and the manufacture thereof
GB1518364A (en) * 1976-05-05 1978-07-19 Beecham Group Ltd Pharmaceutical composition
US4093710A (en) * 1976-07-07 1978-06-06 Sandoz, Inc. Rapid dissolving effervescent granules
JPH01283222A (ja) * 1988-05-10 1989-11-14 Tokai Kapuseru Kk ピコスルフアートナトリウム軟カプセル剤
IT1229568B (it) * 1989-04-17 1991-09-04 Giuliani Spa Composizione farmaceutica per uso orale adatta all'impiego nel lavaggio gastro intestinale, in particolare per uso diagnostico, oppure come lassativo catartico.
US4946939A (en) * 1989-05-30 1990-08-07 The Dow Chemical Company High purity polyether polyols
US5710183A (en) * 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
US6048901A (en) * 1999-04-20 2000-04-11 Braintree Laboratories, Inc. Method of reducing intestinal gas, cramping and anorectal irritation

Also Published As

Publication number Publication date
WO2000048585A1 (en) 2000-08-24
EP1154765A4 (en) 2004-12-01
EP1154765A1 (en) 2001-11-21
EA200100785A1 (ru) 2002-04-25
CA2362355A1 (en) 2000-08-24
HK1043046A1 (zh) 2002-09-06
BR0008385A (pt) 2002-01-29
PL349360A1 (en) 2002-07-15
AU3604600A (en) 2000-09-04
CZ20013043A3 (cs) 2001-11-14
KR20010102323A (ko) 2001-11-15
EA003064B1 (ru) 2002-12-26
HUP0105351A3 (en) 2004-06-28
ZA200106888B (en) 2002-09-27
CN1341016A (zh) 2002-03-20
JP2002537248A (ja) 2002-11-05

Similar Documents

Publication Publication Date Title
BR9911160A (pt) Ciclosporinas
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
CA2222676A1 (en) New pharmaceutical composition with anaesthetic effect
BR9710994A (pt) Derivados anticonvulsivos úteis no tratamento de obesidade.
ATE246514T1 (de) Paclitaxel enthaltende arzneimittel
IT1271462B (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
IS1892B (is) Nýjar samsetningar virkra efna sem innihalda klópidógrel og andþrombín
ZA200300712B (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome.
HK1029290A1 (en) Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
AU2001266152A1 (en) Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
HUP0105351A2 (hu) Pezsgő hashajtó készítmények és alkalmazásuk
PT1007040E (pt) Utilizacao de fanquinona no tratamento da doenca de alzheimer
MY130445A (en) Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone
BR9506956A (pt) Composição farmacêutica antitussígena
EP0744176A3 (en) Methods for inhibiting bone loss
EE04316B1 (et) Asolotriasiinid ja -pürimidiinid, neid sisaldavadfarmatseutilised kompositsioonid ning nende kasutamine ravimite valmistamiseks
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
GEP20043377B (en) Pharmaceutical Complex
HRP20000703B1 (en) Stabile compositions levosimendan and alginic acid
EE9900174A (et) Konformatsiooniliselt fikseeritud LH-RH analoogid, nende kasutamine ja neid sisaldavad farmatseutilised kompositsioonid
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
NO20021429D0 (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
NO991740L (no) Farmas°ytiske og kosmetiske formuleringer med antimikrobiell aktivitet
PL355292A1 (en) Combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino(2,3)-e indol-8-one and neuroleptics